Skip to content

13F-HR filed by Endurant Capital Management LP

Endurant Capital Management LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 53 holding rows worth $439,127,000.

Accession
0001633055-21-000008
Filed
2021-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 53 entries on the cover page, a total value of $439,127,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $439,127,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS25,300$73,812,000thousands by filing dateput
INVACARE CORP461203AJ0NOTE 5.000%11/156,727,000$51,196,000thousands by filing dateprincipal
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock206,800$36,314,000thousands by filing datecall
AbbVie,Inc.00287Y109COM180,429$19,463,000thousands by filing date
HUMANA INC COM444859102Stock44,022$17,131,000thousands by filing date
Johnson & Johnson478160104COM98,077$15,839,000thousands by filing date
HOLOGIC INC436440101COM200,119$14,771,000thousands by filing date
BIO RAD LABS INC090572207CL A18,272$13,630,000thousands by filing date
Bristol-Myers Squibb Company110122108COM211,821$12,533,000thousands by filing date
ICON PUB LTD CO SHSG4705A100Stock46,720$12,242,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock179,288$11,912,000thousands by filing date
SI BONE INC825704109COM471,214$10,093,000thousands by filing date
SYNEOS HEALTH INC87166B102CL A92,761$8,115,000thousands by filing date
VERACYTE INC COM92337F107Stock168,211$7,813,000thousands by filing date
Cigna Corporation125523100COM36,188$7,243,000thousands by filing date
ELUTIA INC05479K106CL A COM952,610$6,625,000thousands by filing date
AVANTOR INC COM05352A100Stock161,963$6,624,000thousands by filing date
MCKESSON CORP COM58155Q103Stock32,551$6,490,000thousands by filing date
ACCENDRA HEALTH INC690732102COM203,784$6,376,000thousands by filing date
R1 RCM INC749397105COM282,911$6,227,000thousands by filing date
INVACARE CORP461203AL5NOTE 5.000%11/17,000,000$6,207,000thousands by filing dateprincipal
APTARGROUP INC COM038336103Stock51,191$6,110,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM610,401$6,104,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW18,829$5,299,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR917,488$4,743,000thousands by filing date
ADAPTHEALTH CORP00653Q102COMMON STOCK194,886$4,539,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock159,903$4,404,000thousands by filing date
SELECTA BIOSCIENCES INC816212104COM1,021,501$4,249,000thousands by filing date
MOLECULAR TEMPLATES INC608550109COM613,630$4,117,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK117,328$3,661,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM1,132,523$3,522,000thousands by filing date
DENTSPLY SIRONA INC24906P109COM60,620$3,519,000thousands by filing date
REVVITY INC714046109COM19,264$3,338,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM131,098$3,233,000thousands by filing date
PRAXIS PRECISION MEDICINES I74006W108COM153,599$2,840,000thousands by filing date
BECTON DICKINSON & CO075887109COM11,077$2,723,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR54,821$2,643,000thousands by filing date
CENCORA INC COM03073E105Stock21,430$2,560,000thousands by filing date
REGULUS THERAPEUTICS INC75915K200COM NEW3,547,208$2,450,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM389,833$2,394,000thousands by filing date
DARIOHEALTH CORP23725P209COM150,004$2,048,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN746,514$1,807,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock52,048$1,716,000thousands by filing date
IMMUNIC INC4525EP101COM185,448$1,641,000thousands by filing date
MARAVAI LIFESCIENCES HLDGS A56600D107COMMON STOCK29,838$1,464,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock67,300$1,211,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock22,938$1,198,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM90,041$1,139,000thousands by filing date
ALLOVIR INC019818103COM44,430$1,113,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock62,743$959,000thousands by filing date
PATTERSON COS INC703395103COM26,799$808,000thousands by filing date
CELYAD ONCOLOGY SA151205200ADR145,380$596,000thousands by filing date
INVACARE CORP461203101COMMON STOCK1,146,068$323,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001633055-21-000008this filing2021-11-15acceptance time not in the bulk data set